Plasmodium
Plasmodium - most related articles:
-
Malaria during pregnancy first trimester - antimalarial is safe - 3.2
-
Malarial parasite plasmodium vivax more serious - 3.1
-
Novel antimalarial drug candidate identified - 3
-
Promising candidates for malaria vaccine revealed - 2.8
-
New lead on malaria treatment - 2.5
-
A pre existing malaria infection can prevent a second infection - 2.4
-
125.2 million pregnant women at risk of malaria - 2.1
-
Genes identified causing antimalarial drug resistance - 2
Plasmodium articles
New malaria vaccine may make all strains of malaria parasite ineffectiveA new candidate malaria vaccine with the potential to neutralise all strains of the most deadly species of malaria parasite has been developed by a team led by scientists at the University of Oxford, UK.
Malaria mosquitoes can't spot a spermless mateA female mosquito cannot tell if the male that she has mated with is fertile or 'sperm less' and unable to fertilize her eggs, according to a recent study from scientists at Imperial College London.
A pre existing malaria infection can prevent a second infectionA team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host.
Genes identified causing antimalarial drug resistanceUsing a pair of powerful genome-search techniques, researchers from the Harvard School of Public Health (HSPH), Harvard University, and the Broad Institute have identified several genes that may be implicated in the malaria parasite's notorious ability to rapidly evade drug treatments.
Novel antimalarial drug candidate identifiedNovartis announced that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.
Novel anti malarial drug candidate foundAs part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs.
New treatment targets for malaria releasedInternational collaboration led by St. Jude Children's Research Hospital scientists identifies promising compounds for anti-malarial drug development and launches a database to share findings, advance fight against a leading killer of the world's children
Increase funding for global fight against malariaA new study linking funding increases in the global fight against malaria to a drop in deaths from the disease also shows that resources from donor governments still fall short of those needed for maximum impact against the world's fourth-biggest killer of children, according to a global health policy analyst at international aid agency World Vision.
Egyptian pharaoh King Tutankhamun died of malariaMalaria and bone abnormalities appear to have contributed to the death of Egyptian pharaoh King Tutankhamun, revealed by researchers.
125.2 million pregnant women at risk of malariaResearch published this week in PLoS Medicine concludes that at least 125.2 million women at risk of malaria become pregnant each year.
Promising candidates for malaria vaccine revealedWalter and Eliza Hall Institute researchers have uncovered a group of proteins that could form the basis of an effective vaccine against malaria.
Measuring and modeling blood flow in malariaWhen people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
Coffee ring stain diagnostic test for malaria - Gates FoundationThe US' Gates Foundation funds development of coffee ring stain diagnostic test for malaria. Vanderbilt University received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.
Artemisinin based anti malarial drugs becoming resistant to malariaMalaria parasites in western Cambodia have become resistant to artemisinin based therapies, the first-line treatment for malaria, revealed by researchers.
New lead on malaria treatmentApproximately 350 million to 500 million cases of malaria are diagnosed each year mostly in sub-Saharan Africa. While medications to prevent and treat malaria do exist, the demand for new treatments is on the rise, in part, because malaria parasites have developed a resistance to existing medications.
New drug aims to transform malaria treatmentRanbaxy Laboratories Limited (Ranbaxy) announced the commencement of Phase-III clinical trials for its new Anti-malaria combination drug, Arterolane maleate + Piperaquine phosphate in India, Bangladesh and Thailand.
Malaria diagnostic tests differ in performanceThe largest-ever independent, laboratory-based evaluation of rapid diagnostic tests (RDTs) for malaria has shown that some tests on the market perform exceptionally well in tropical temperatures and can detect even low parasite densities in blood samples, while other tests can detect parasites only at high densities.
Make this world malaria freeProgress has been made in combating malaria, particularly in Africa where the disease is most prevalent, but more must be done to address the global scourge, UNICEF said, as it released a new joint report on the eve of World Malaria Day.
Zambian success in fight against malariaMalaria deaths reported from health facilities in Zambia have declined by 66%. This result along with other supporting data indicates that Zambia has reached the 2010 Roll Back Malaria target of a more than 50% reduction in malaria mortality compared to 2000.
Monash research breakthrough to treat malariaAustralian researchers have made a major breakthrough in the international fight against malaria, which claims the life of a child across the world every 30 seconds.
Malarial parasite plasmodium vivax more seriousPlasmodium vivax can cause severe malaria associated with substantial morbidity and mortality, show two studies published in PLoS Medicine this week. These findings challenge the current dogma that P. falciparum can be severe and life-threatening whereas Plasmodium vivax tends to be mild, according to the related commentary by Stephen Rogerson (University of Melbourne, Australia), an expert not connected with these studies.
21 Plasmodium articles listed above.